Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 11, 2011 - Issue 1
Submit an article Journal homepage
92
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Microarray technology displays the complexities of the humoral immune response

Phillip Stafford Biodesign Institute, Arizona State University, AZ, USA
&
Stephen Johnston Biodesign Institute, Arizona State University, 1001 S. McAllister Ave., Tempe, AZ 85287, USA. [email protected]
Pages 5-8 | Published online: 09 Jan 2014

References

  • Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr. Infect. Dis. J.20(1), 63–75 (2001).
  • Acierno JP, Braden BC, Klinke S, Goldbaum FA, Cauerhff A. Affinity maturation increases the stability and plasticity of the Fv domain of anti-protein antibodies. J. Mol. Biol.374, 130–146 (2007).
  • McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature348, 552–554 (1990).
  • Burton DR, Barbas CF 3rd, Persson MA, Koenig S, Chanock RM, Lerner RA. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic individuals. Proc. Natl Acad. Sci. USA88, 10134–10137 (1991).
  • Jespers LS, Roberts A, Mahler SM, Winter G, Hoogenboom HR. Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen. Nat. Biotechnol.12(9), 899–903 (1994).
  • Cortese R, Monaci P, Luzzago A et al. Selection of biologically active peptides by phage display of random peptide libraries. Curr. Opin. Biotechnol.7, 616–621 (1996).
  • Fisch I, Kontermann RE, Finnern R et al. A strategy of exon shuffling for making large peptide repertoires displayed on filamentous bacteriophage. Proc. Natl Acad. Sci. USA93(15), 7761–7766 (1996).
  • Folgori A, Tafi R, Meola A et al. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J.13(9), 2236–2243 (1994).
  • Irving RA, Coia G, Roberts A, Nuttall SD, Hudson PJ. Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics. J. Immunol. Methods248(1–2), 32–45 (2001).
  • Gold L. mRNA display: diversity matters during in vitro selection. Proc. Natl Acad. Sci. USA98(9), 4825–4826 (2001).
  • Fukuda I, Kojoh K, Tabata N et al.In vitro evolution of single-chain antibodies using mRNA display. Nucleic Acids Res.34(19), e127 (2006).
  • Douthwaite JA, Groves MA, Dufner P, Jermutus L. An improved method for an efficient and easily accessible eukaryotic ribosome display technology. Protein Eng. Des. Sel.19(2), 85–90 (2006).
  • Haroun M, El-Sayed MM. Measurement of IgG levels can serve as a biomarker in newly diagnosed diabetic children. J. Clin. Biochem. Nutr.41(1), 56–61 (2006).
  • Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum.25, 1271–1277 (1982).
  • Desmetz C, Maudelonde T, Mangé A, Solassol J. Identifying autoantibody signatures in cancer: a promising challenge. Expert Rev. Proteomics6(4), 377–386 (2009).
  • Fritzler MJ. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun. Rev.7, 616–620 (2008).
  • Anderson L, Anderson NG. The human plasma proteome. Mol. Cell. Proteomics1, 845–867 (2002).
  • Zhu H, Snyder M. Protein arrays and microarrays. Curr. Opin. Chem. Biol.5(1), 40–45 (2001).
  • Anderson KS, LaBaer J. The sentinel within: exploiting the immune system for cancer biomarkers. J. Proteome Res.4(4), 1123–1133 (2005).
  • Hudson ME, Pozdnyakova I, Haines K et al. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc. Natl Acad. Sci. USA104(44), 17494–17499 (2007).
  • Kijanka G, Murphy D. Protein arrays as tools for serum autoantibody marker discovery in cancer. J. Proteomics72, 936–944 (2009).
  • Li L, Chen A, Chaudhuri A et al. Compartmental localization and clinical relevance of MICA antibodies after renal transplantation. transplantation89(3), 312–319 (2010).
  • Caiazzo RJ Jr, Tassinari OW, Ehrlich JR, Liu BC. Autoantibody microarrays for biomarker discovery. Expert Rev. Proteomics4(2), 261–272 (2007).
  • Gnjatic S, Ritter E, Büchler MW et al. Seromic profiling of ovarian and pancreatic cancer. Proc. Natl Acad. Sci. USA107(11), 5088–5093 (2010).
  • Andresen H, Grotzinger C. Deciphering the antibodyome – peptide arrays for serum antibody biomarker diagnostics. Curr. Proteomics6, 1–12 (2009).
  • Andresen H, Grötzinger C, Zarse K, Kreuzer OJ, Ehrentreich-Förster E, Bier FF. Functional peptide microarrays for specific and sensitive antibody diagnostics. Proteomics6(5), 1376–1384 (2006).
  • Schaller RR. Moore’s law: past, present and future. IEEE Spectrum34(6), 52–59 (1997).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.